Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults
Clinical trial NCT04776317 · COMPLETED
Trial details
- NCT number
- NCT04776317
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2023-09-15
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.